American Healthcare REIT, Inc. SEC filings AHR

American Healthcare REIT, Inc. has 858 filings in SEC EDGAR's recent list, going back to Feb 10, 2015. Its latest annual report, Form 10-K, was filed on Feb 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

American Healthcare REIT, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2026 Nov 5, 2026
3 Initial insider ownership Oct 2, 2026 Oct 1, 2026
4 Insider transaction Sep 28, 2026 Sep 25, 2026
144 Notice of proposed sale Sep 25, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Sep 18, 2026 Sep 18, 2026
8-K Current report
Regulation FD disclosure
Sep 14, 2026 Sep 14, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 2, 2026 Sep 2, 2026
4 Insider transaction Sep 1, 2026 Sep 1, 2026
144 Notice of proposed sale Sep 1, 2026 —
8-K Current report
Regulation FD disclosure
Sep 1, 2026 Sep 1, 2026
8-K Current report
Other events
Aug 24, 2026 Aug 20, 2026
8-K Current report
Other events
Aug 12, 2026 Aug 10, 2026
424B5 Prospectus supplement Aug 11, 2026 —
424B5 Prospectus supplement Aug 10, 2026 —
8-K Current report
Material agreement
Aug 10, 2026 Aug 10, 2026
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
Aug 6, 2026 Aug 6, 2026
4/A Filing Aug 4, 2026 Jul 21, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 27, 2026 —
4 Insider transaction Jul 22, 2026 Jul 21, 2026
4 Insider transaction Jul 22, 2026 Jul 21, 2026
4 Insider transaction Jul 22, 2026 Jul 21, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 22, 2026 Jul 20, 2026
4 Insider transaction Jun 29, 2026 Jun 26, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
144 Notice of proposed sale Jun 26, 2026 —
8-K Current report
Shareholder vote results
Jun 25, 2026 Jun 24, 2026
144 Notice of proposed sale Jun 24, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jun 18, 2026 Jun 18, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
144 Notice of proposed sale Jun 1, 2026 —
8-K Current report
Other events
May 28, 2026 May 26, 2026
8-K Current report
Other events
May 22, 2026 May 20, 2026
424B5 Prospectus supplement May 21, 2026 —
424B5 Prospectus supplement May 20, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 12, 2026 —
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 7, 2026 May 7, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 28, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 23, 2026 —
DEF 14A Proxy statement Apr 9, 2026 Apr 9, 2026
4 Insider transaction Apr 8, 2026 Apr 6, 2026
4 Insider transaction Apr 8, 2026 Apr 6, 2026
4 Insider transaction Apr 8, 2026 Apr 6, 2026
4 Insider transaction Apr 8, 2026 Apr 6, 2026
4 Insider transaction Apr 8, 2026 Apr 6, 2026
8-K Current report
Material agreement, New debt
Apr 7, 2026 Apr 1, 2026
4 Insider transaction Mar 30, 2026 Mar 26, 2026
4 Insider transaction Mar 27, 2026 Mar 25, 2026
4 Insider transaction Mar 27, 2026 Mar 25, 2026
4 Insider transaction Mar 27, 2026 Mar 25, 2026
4 Insider transaction Mar 27, 2026 Mar 25, 2026
4 Insider transaction Mar 27, 2026 Mar 25, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
144 Notice of proposed sale Mar 25, 2026 —
8-K/A Amended current report
Officer or director change
Mar 24, 2026 Feb 3, 2026
8-K Current report
Regulation FD disclosure, Other events
Mar 18, 2026 Mar 18, 2026
4 Insider transaction Mar 16, 2026 Mar 12, 2026
4 Insider transaction Mar 16, 2026 Mar 12, 2026
4 Insider transaction Mar 16, 2026 Mar 12, 2026
4 Insider transaction Mar 16, 2026 Mar 12, 2026
4 Insider transaction Mar 16, 2026 Mar 12, 2026
8-K Current report
Material agreement
Feb 27, 2026 Feb 27, 2026
424B5 Prospectus supplement Feb 27, 2026 —
10-K Annual report Feb 27, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 26, 2026 Feb 26, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 13, 2026 —
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 6, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 6, 2026 —
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 4, 2026 Feb 3, 2026
4 Insider transaction Dec 29, 2025 Dec 22, 2025
144 Notice of proposed sale Dec 22, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Dec 16, 2025 Dec 16, 2025
8-K Current report
Other events
Nov 26, 2025 Nov 24, 2025
8-K Current report
Other events
Nov 24, 2025 Nov 20, 2025
424B5 Prospectus supplement Nov 21, 2025 —
424B5 Prospectus supplement Nov 20, 2025 —
4 Insider transaction Nov 12, 2025 Nov 11, 2025
144 Notice of proposed sale Nov 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 12, 2025 —
4 Insider transaction Nov 10, 2025 Nov 10, 2025
144 Notice of proposed sale Nov 10, 2025 —
10-Q Quarterly report Nov 7, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 6, 2025 Nov 6, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 18, 2025 Sep 18, 2025
4 Insider transaction Sep 5, 2025 Sep 3, 2025
144 Notice of proposed sale Sep 3, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 11, 2025 —
424B5 Prospectus supplement Aug 8, 2025 —
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
8-K Current report
Material agreement
Aug 8, 2025 Aug 8, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 7, 2025 Aug 7, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2025 —
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
144 Notice of proposed sale Jun 27, 2025 —
8-K Current report
Shareholder vote results
Jun 26, 2025 Jun 25, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 20, 2025 Jun 20, 2025
10-Q Quarterly report May 9, 2025 Mar 31, 2025
8-K/A Amended current report
Results of operations
May 9, 2025 May 8, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 8, 2025 May 8, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 30, 2025 —
DEF 14A Proxy statement Apr 10, 2025 Apr 10, 2025
4 Insider transaction Apr 7, 2025 Apr 3, 2025
4 Insider transaction Apr 7, 2025 Apr 3, 2025
4 Insider transaction Apr 7, 2025 Apr 3, 2025
4 Insider transaction Apr 7, 2025 Apr 3, 2025
4 Insider transaction Apr 7, 2025 Apr 3, 2025
4 Insider transaction Mar 26, 2025 Mar 25, 2025
4 Insider transaction Mar 26, 2025 Mar 25, 2025
4 Insider transaction Mar 26, 2025 Mar 25, 2025
4 Insider transaction Mar 26, 2025 Mar 25, 2025
4 Insider transaction Mar 26, 2025 Mar 25, 2025
8-K Current report
Regulation FD disclosure, Other events
Mar 19, 2025 Mar 19, 2025
4 Insider transaction Mar 17, 2025 Mar 14, 2025
4 Insider transaction Mar 17, 2025 Mar 14, 2025
4 Insider transaction Mar 17, 2025 Mar 14, 2025
4 Insider transaction Mar 17, 2025 Mar 14, 2025
4 Insider transaction Mar 17, 2025 Mar 14, 2025
10-K Annual report Feb 28, 2025 Dec 31, 2024
8-K Current report
Acquisition or sale of assets, Regulation FD disclosure
Feb 27, 2025 Feb 27, 2025
8-K Current report
Bylaw or fiscal year change
Feb 24, 2025 Feb 21, 2025
4 Insider transaction Feb 12, 2025 Feb 10, 2025
4 Insider transaction Feb 12, 2025 Feb 10, 2025
4 Insider transaction Feb 12, 2025 Feb 10, 2025
4 Insider transaction Feb 12, 2025 Feb 10, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 8, 2025 —
4 Insider transaction Jan 3, 2025 Jan 2, 2025
8-K Current report
Regulation FD disclosure, Other events
Dec 18, 2024 Dec 18, 2024
S-8 Employee stock plan registration Nov 20, 2024 —
8-K Current report
Material agreement
Nov 18, 2024 Nov 18, 2024
424B5 Prospectus supplement Nov 18, 2024 —
SC 13G Ownership over 5% (passive) Nov 13, 2024 —
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
4 Insider transaction Nov 12, 2024 Nov 7, 2024
4 Insider transaction Nov 12, 2024 Nov 7, 2024
4 Insider transaction Nov 12, 2024 Nov 7, 2024
4 Insider transaction Nov 12, 2024 Nov 7, 2024
4 Insider transaction Nov 12, 2024 Nov 7, 2024
4 Insider transaction Nov 12, 2024 Nov 7, 2024
4 Insider transaction Nov 12, 2024 Nov 7, 2024
4 Insider transaction Nov 12, 2024 Nov 7, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 12, 2024 Nov 12, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
8-K Current report
Shareholder vote results
Nov 8, 2024 Nov 7, 2024
SC 13G Ownership over 5% (passive) Nov 8, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 8, 2024 —
SC 13G Ownership over 5% (passive) Nov 4, 2024 —
SC 13G Ownership over 5% (passive) Oct 24, 2024 —
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 3, 2024 Oct 1, 2024
4 Insider transaction Oct 3, 2024 Oct 1, 2024
4 Insider transaction Oct 3, 2024 Oct 1, 2024
8-K Current report
Material agreement, Other events
Sep 20, 2024 Sep 18, 2024
424B2 Prospectus Sep 19, 2024 —
424B5 Prospectus supplement Sep 18, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Sep 6, 2024 Sep 6, 2024
DEF 14A Proxy statement Aug 28, 2024 Aug 28, 2024
S-3ASR Automatic shelf registration Aug 12, 2024 —
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Real Estate Investment Trusts (SIC 6798)
Listed as
AHR (NYSE)
Fiscal year ends
December 31
Incorporated in
MD
Headquarters
Irvine, CA
SEC filer status
Large accelerated filer
SEC CIK
1632970
Former names
Griffin-American Healthcare REIT IV, Inc. (until Sep 30, 2021); Griffin-American Healthcare REIT 4, Inc. (until Oct 23, 2015)

Other Real Estate Investment Trusts companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.